Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Almenar-Bonet

Showing results (51-60 of 131) with videos related to

Pageof 14
Sort By:
Revista Espanola De Cardiologia|February 12, 2011
Repeated daclizumab administration to delay the introduction of calcineurin inhibitors in heart transplant patients with postoperative renal dysfunctionIgnacio J Sánchez Lázaro, Luis Almenar Bonet, Luis Martínez Dolz, et al.
ESC Heart Failure|June 24, 2022
Experience with the potassium binder patiromer in hyperkalaemia management in heart failure patients in real lifeAlberto Esteban-Fernández, Carolina Ortiz Cortés, Silvia López-Fernández, et al.
International Journal of Environmental Research and Public Health|November 26, 2022
Well-Being, Physical Activity, and Social Support in Octogenarians with Heart Failure during COVID-19 Confinement: A Mixed-Methods StudyElena Marques-Sule, Elena Muñoz-Gómez, Luis Almenar-Bonet, et al.
ESC Heart Failure|May 5, 2023
Therapeutic approach in heart failure with poor diuretic response: peripheral ultrafiltration vs. conventional treatmentRaquel López-Vilella, Borja Guerrero Cervera, Ignacio Sánchez-Lázaro, et al.
ISRN Cardiology|July 11, 2012
Ischemic time as a predictor of physical recovery in the first months after heart transplantationFrancisco Buendía-Fuentes, Luis Almenar-Bonet, Luis Martínez-Dolz, et al.
Biomedicines|February 27, 2026
Cardiorenal and Metabolic Convergence in Acute Heart Failure: Severe Cardiorenometabolic Syndrome as a High-Risk PhenotypeRaquel López-Vilella, Borja Guerrero Cervera, Julia Martínez Solé, et al.
The American Journal of Cardiology|January 21, 2011
Relation of soluble receptor for advanced glycation end products to predict mortality in patients with chronic heart failure independently of Seattle Heart Failure ScoreSergio Raposeiras-Roubín, Bruno K Rodiño-Janeiro, Lilian Grigorian-Shamagian, et al.
Transplantation|April 26, 2021
Plasma Levels of SERCA2a as a Noninvasive Biomarker of Primary Graft Dysfunction After Heart TransplantationSilvia Lozano-Edo, Ignacio Sánchez-Lázaro, Manuel Portolés, et al.
Reviews in Cardiovascular Medicine|January 12, 2026
Combination of the Fibrosis 4 Index and Carbohydrate Antigen 125 to Predict Morbidity and Mortality in Acute Heart FailureFranco Appiani, Raquel López-Vilella, Víctor Donoso, et al.
Transplantation Proceedings|October 2, 2021
Usefulness of Immunoglobulin A in Patients With Decompensated Heart Failure: Is It a Future Marker of Congestion? Preliminary ExperienceRaquel López-Vilella, Patricia Arenas Martín, Víctor Donoso Trenado, et al.
Pageof 14

Showing results (51-60 of 131) with videos related to

Sort By:
Pageof 14
Revista Espanola De Cardiologia|February 12, 2011
Repeated daclizumab administration to delay the introduction of calcineurin inhibitors in heart transplant patients with postoperative renal dysfunctionIgnacio J Sánchez Lázaro, Luis Almenar Bonet, Luis Martínez Dolz, et al.
ESC Heart Failure|June 24, 2022
Experience with the potassium binder patiromer in hyperkalaemia management in heart failure patients in real lifeAlberto Esteban-Fernández, Carolina Ortiz Cortés, Silvia López-Fernández, et al.
International Journal of Environmental Research and Public Health|November 26, 2022
Well-Being, Physical Activity, and Social Support in Octogenarians with Heart Failure during COVID-19 Confinement: A Mixed-Methods StudyElena Marques-Sule, Elena Muñoz-Gómez, Luis Almenar-Bonet, et al.
ESC Heart Failure|May 5, 2023
Therapeutic approach in heart failure with poor diuretic response: peripheral ultrafiltration vs. conventional treatmentRaquel López-Vilella, Borja Guerrero Cervera, Ignacio Sánchez-Lázaro, et al.
ISRN Cardiology|July 11, 2012
Ischemic time as a predictor of physical recovery in the first months after heart transplantationFrancisco Buendía-Fuentes, Luis Almenar-Bonet, Luis Martínez-Dolz, et al.
Biomedicines|February 27, 2026
Cardiorenal and Metabolic Convergence in Acute Heart Failure: Severe Cardiorenometabolic Syndrome as a High-Risk PhenotypeRaquel López-Vilella, Borja Guerrero Cervera, Julia Martínez Solé, et al.
The American Journal of Cardiology|January 21, 2011
Relation of soluble receptor for advanced glycation end products to predict mortality in patients with chronic heart failure independently of Seattle Heart Failure ScoreSergio Raposeiras-Roubín, Bruno K Rodiño-Janeiro, Lilian Grigorian-Shamagian, et al.
Transplantation|April 26, 2021
Plasma Levels of SERCA2a as a Noninvasive Biomarker of Primary Graft Dysfunction After Heart TransplantationSilvia Lozano-Edo, Ignacio Sánchez-Lázaro, Manuel Portolés, et al.
Reviews in Cardiovascular Medicine|January 12, 2026
Combination of the Fibrosis 4 Index and Carbohydrate Antigen 125 to Predict Morbidity and Mortality in Acute Heart FailureFranco Appiani, Raquel López-Vilella, Víctor Donoso, et al.
Transplantation Proceedings|October 2, 2021
Usefulness of Immunoglobulin A in Patients With Decompensated Heart Failure: Is It a Future Marker of Congestion? Preliminary ExperienceRaquel López-Vilella, Patricia Arenas Martín, Víctor Donoso Trenado, et al.
Pageof 14